| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC0885 |
| Trial ID | ChiCTR2000038015 |
| Disease | NKG2DL+ Tumor |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | NKG2D CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | One-Center, Open-Label, Single-Arm Clinical Study of the Safety and Effectiveness of NKG2D CAR-T Cells Infusion in the Treatment of Relapsed or Refractory NKG2DL+ Tumors |
| Year | 2020 |
| Country | China |
| Company sponsor | The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital |
| Cohort 1 | |||||||
|
|||||||